UChicago’s Pritzker School of Medicine calls for discussion on ratings system as it withdraws from U.S. News rankings

The Pritzker School of Medicine at the University of Chicago announced that it will not participate in U.S. News & World Report’s annual “Best Medical Schools” ranking next year due to concerns about the publication’s methodology and the impact the ratings system has on ensuring equity in medical education.

UChicago Medicine performs 66 heart transplants in 2022, sets new state record for 2nd consecutive year

With the successful completion of back-to-back Christmas heart transplants, the University of Chicago Medicine set a new heart transplantation record for the state of Illinois, surpassing its own previous high-water mark for heart transplants. The Hyde Park-based academic health system has performed 66 heart transplants so far in 2022, surpassing last year’s record of 61.

UChicago Medicine transplant team performs health system’s historic first DCD heart transplant

The University of Chicago Medicine transplant team performed the health system’s first donated-after-circulatory death (DCD) heart transplant on Nov. 19, 2022. The DCD technique is expected to help heart patients get transplants faster. Donor hearts are traditionally recovered from brain-dead donors, a process known as donation after brain death (DBD).

UChicago Medicine earns high marks for stem cell transplant survival rates

New data show the University of Chicago Medicine’s David and Etta Jonas Center for Cellular Therapy has the highest one-year survival rate in Illinois for adults undergoing blood and bone marrow stem cell transplants. UChicago Medicine had an 80% one-year survival rate among adult stem cell patients, according to the latest statistics released in mid-December by the Center for International Blood & Marrow Transplant Research (CIBMTR).

UChicago Medicine, Legal Aid Chicago launch bedside program to provide in-hospital legal support for trauma patients injured by violence

The University of Chicago Medicine has launched a novel partnership with Legal Aid Chicago, embedding two full-time lawyers within the health system’s Level 1 trauma center to provide civil legal support to patients who’ve been injured from intentional violence.

UCMC named ‘Top Teaching Hospital’ by leading industry watchdog Leapfrog Group

The University of Chicago Medical Center has been named a “Top Teaching Hospital” by The Leapfrog Group for the fifth time, recognizing the academic medical center’s long record of providing patients with safe, world-class healthcare while educating future clinicians. The industry watchdog organization designated 58 academic medical centers across the country as “Top Teaching Hospitals” on its 2022 Top Hospitals list, which was published Tuesday, December 6.

University of Chicago Medical Center earns 22nd consecutive ‘A’ grade for patient safety, retains 10-year run in elite group

The University of Chicago Medical Center has earned its 22nd consecutive ‘A’ grade in hospital and patient safety from The Leapfrog Group, extending a 10-year run of scoring top honors from the independent watchdog organization. Of the thousands of acute-care facilities nationwide, the 811-bed University of Chicago Medical Center is one of only 22 hospitals in the country to have earned the top grade in all 22 of The Leapfrog Group’s semiannual report cards, which began in 2012.

UChicago Medicine’s heart transplant program makes history again, with best survival rates and wait times ever recorded

The University of Chicago Medicine’s heart transplant program is making history once again. The program’s transplant survival rates and transplant wait times are not only the best in the country, but they’re the best in the history of heart transplantation, according to an analysis of Scientific Registry of Transplant Recipients (SRTR) data.

$10 million gift to support ALS research, educational outreach at local high schools

The University of Chicago has received a $10 million gift from the Lohengrin Foundation to help establish a center of excellence in research on amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. ALS and its related conditions are devastating neurological diseases. Also known as Lou Gehrig’s disease, ALS progressively destroys nerve cells that control body movements, and affects as many as 30,000 Americans each year.

Collaborative between UChicago Medicine and Advocate Health Care supports 18 grassroots organizations helping to keep kids safe this summer

Eighteen South Side community groups are receiving $150,000 to support their grassroots work supporting youth and keeping them safe during the summer — a time when violence and violent injuries typically increases in the Chicagoland area. The funding is made possible through the annual grants program from Southland RISE (Resilience Initiative to Strengthen and Empower), a collaborative uniting the trauma recovery programs from the University of Chicago Medicine and Advocate Health Care.

UChicago Medicine breaks ground on $121M multispecialty care facility in Crown Point, Indiana

The University of Chicago Medicine broke ground on a new two-story, 130,000-square-foot multispecialty care center and micro-hospital in Northwest Indiana for what will be the academic health system’s largest off-site facility and its first freestanding building in Indiana. The $121 million state-of-the-art care center, at I-65 and 109th Avenue in Crown Point, is expected to open in spring of 2024.

Comparing African and European populations leads to breast cancer risk discovery

By comparing genetic data from European and African population groups, scientists at UChicago Medicine Comprehensive Cancer Center have identified seven new regions of the human genome that are associated with increased breast cancer risk. The findings were published in Nature Communications.

Are childhood cancers different? Understanding the immune response to tumors in pediatric neuroblastoma

UChicago Medicine physician-scientists aimed to find out how the immune systems of children with a type of cancer called neuroblastoma respond to tumors. The answer to this question could help guide the treatment of pediatric patients.

UChicago Medicine’s community benefit investment totals $567.1 million in fiscal 2020

The UChicago Medicine health system provided $567.1 million in community benefits and services to the South Side, and UChicago Medicine Ingalls Memorial provided $89.5 million to Harvey and nearby areas.

$10 million grant from AbbVie Foundation to support UChicago Medicine Comprehensive Cancer Center

A $10 million grant from the AbbVie Foundation will support scientific and educational activities at the University of Chicago Medicine Comprehensive Cancer Center under the leadership of a newly appointed Cancer Center Director Kunle Odunsi, MD, PhD.

Adekunle Odunsi named new director of University of Chicago Medicine Comprehensive Cancer Center

Adekunle “Kunle” Odunsi, MD, PhD, FRCOG, FACOG, an expert in immunotherapy and vaccine therapy for cancer, has been appointed director of the University of Chicago Medicine Comprehensive Cancer Center. He comes to Chicago from Buffalo, New York, where he served as deputy director at Roswell Park Comprehensive Cancer Center.

UChicago Medicine receives recognition for resuscitation and stroke care

The American Heart Association has recognized Comer Children’s Hospital with its top honor for resuscitation care of newborns and children, and University of Chicago Medicine with its top honor for stroke care. The awards reflect commitment to high-quality, advanced care for children and adults.

UChicago Medicine, in partnership with Solis Mammography, opens two new breast health centers

Solis Mammography, the nation’s largest independent provider of breast health and diagnostic services, is expanding access to 3D mammography and diagnostic breast health procedures through a partnership with University of Chicago Medicine.

[email protected] experts can discuss #Tocilizumab research; Drug may reduce need for ventilators in #COVID19 pneumonia

Roche made news today as research showed its drug (tocilizumab) reduced patients’ need for ventilators for those with COVID-19-associated pneumonia. A University of Chicago Medicine team has done separate, independent research on tocilizumab and found similar results in their own phase II trial.…

UChicago bioinformatics team to create data infrastructure for global pediatric cancer initiative

The University of Chicago Pediatric Cancer Data Commons and The Leukemia and Lymphoma Society are working together to bring precision medicine to children and young adults with acute leukemia.

UChicago Medicine joins BOOST-3 national trial to investigate treatments for traumatic brain injuries

As part of nationwide study to improve trauma care for severe brain injuries, researchers at UChicago Medicine are working to engage South Side residents and ensure representation among underrepresented communities.

$500,000 gift supports worldwide effort to harness pediatric cancer data to advance treatment for children

Family looks to the ‘bright side’ by creating a charity to support pediatric cancer research and providing UChicago Medicine Comer Children’s Hospital with $500,000 gift.

UChicago Medicine selected as Chicago’s only official NIH network site researching stroke and dementia

About 30% of stroke patients develop dementia, yet researchers understand very little about why. UChicago Medicine joins a NIH-led national network of institutions working to better understand the risk factors that lead to vascular cognitive impairment and dementia (VCID), early stroke recovery and approaches to prevention.